GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Ankur Khosla, Md, MD | Pain Medicine | Shenandoah, TX | $2,584 | $0 |
| Dr. Eric Cornidez, M.d, M.D | Anesthesiology | Tucson, AZ | $2,522 | $0 |
| Dr. Devin Peck, M.d, M.D | Pain Medicine | Georgetown, TX | $2,485 | $0 |
| Bennett Ezekiel, M.d, M.D | Physical Medicine & Rehabilitation | Georgetown, TX | $2,385 | $0 |
| John Santoro, Dpm, DPM | Podiatrist | Murrieta, CA | $2,337 | $0 |
| Adnan Khan, M.d, M.D | Pain Medicine | Georgetown, TX | $2,279 | $0 |
| Dr. Kenneth Zaslav, Md, MD | Orthopaedic Surgery | Richmond, VA | $2,250 | $0 |
| Dr. Eduardo Jusino, M.d, M.D | Pain Medicine | Lake Worth, FL | $2,213 | $0 |
| Dr. Efrain Cubillo, Md, MD | Pain Medicine | Tucson, AZ | $2,209 | $0 |
| Donald Bacon, M.d, M.D | Pain Medicine | San Antonio, TX | $2,163 | $0 |
| Dr. Dane Pohlman, D.o, D.O | Pain Medicine | Coral Springs, FL | $2,159 | $0 |
| Dr. Ashu Goyle, Do, DO | Pain Medicine | Scottsdale, AZ | $2,152 | $0 |
| Dr. Adam Shestack, M.d, M.D | Pain Medicine | Delray Beach, FL | $2,143 | $0 |
| Dr. Michael Baskin, Md, MD | Pain Medicine | Boynton Beach, FL | $2,143 | $0 |
| Mrs. Larina Gutenberg, Do, DO | Anesthesiology | San Antonio, TX | $2,142 | $0 |
| Dr. Michael Bush, M.d, M.D | Specialist | Beverly Hills, CA | $2,132 | $0 |
| Dr. Omar Viswanath, M.d, M.D | Pain Medicine | Phoenix, AZ | $2,125 | $0 |
| Evan Franke, M.d, M.D | Anesthesiology | Phoenix, AZ | $2,105 | $0 |
| Dr. Ameet Nagpal, Md, Ms, MD, MS | Physical Medicine & Rehabilitation | Charleston, SC | $2,105 | $0 |
| Amitabh Gulati, Md, MD | Pain Medicine | New York, NY | $2,103 | $0 |
| Unknown Provider | — | — | $2,095 | $0 |
| Dr. Patrick Hogan, D.o, D.O | Pain Medicine | Glendale, AZ | $2,075 | $0 |
| Bradley Ivan, Pa-C, PA-C | Physician Assistant | Chicago, IL | $2,061 | $0 |
| Dr. Hemant Kalia, Md Mph, MD MPH | Interventional Pain Medicine | Rochester, NY | $2,000 | $0 |
| Dr. Rory Abrams, Md, MD | Neurology | New York, NY | $1,600 | $0 |
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.